Pharma & Biotech
-
Providing Non-Opioid Pain Relief, Newtown Square’s Innocoll Sees Surge in Share Price
The recent announcement of positive trial results for its new pain relief treatment sparked a surge in the share price of Newtown Square’s specialty pharmaceutical company, Innocoll Holdings, writes Linda Loyd for the Philadelphia Inquirer. The company said that its non-opioid implant for postoperative pain relief has met “statistical significance” in patients without the additional…
-
Radnor’s Mitochon Pharmaceuticals Receives $1.6M from Private Stock Sale
Radnor-based Mitochon Pharmaceuticals recently completed a private stock sale, generating $1.6 million for the biotech company. Among the investors involved in the equity financing is Ben Franklin Technology Partners of Southeastern Pennsylvania, writes John George of the Philadelphia Business Journal. The start-up company will use the funds to advance the development and testing of its lead…
-
ACME Improves Delco’s Access to Naloxone, Emergency Drug for Opioid Overdose
ACME Markets, Delaware County District Attorney Jack Whelan, and Delaware County Councilman Dave White have announced the availability of Narcan (naloxone) Nasal Spray in all ACME pharmacies across the county. According to the U.S. Centers for Disease Control and Prevention (CDC), naloxone has saved 26,463 lives nationwide over the past 20 years. Since November 2014,…
-
Irish Drug Company Appoints President of U.S. Operations in Radnor
Adapt Pharma, the Dublin, Ireland-based drug company, has appointed Mike Kelly as president of U.S. operations, located in Radnor, writes John George of the Philadelphia Business Journal. The company is renowned as the maker of the Narcan nasal spray used to treat patients suffering from overdoses of heroin and other opioid medicines. Kelly will be…
Founding Partners
Advertisement
Affiliate Partners
Chamber Partners
